• 2015. Retrieved June 5, 2015. "Abbvie Terminates Development Deal with Halozyme – GEN". GEN. 21 November 2016. "AbbVie to Acquire Stemcentrx for Up to...
    39 KB (3,327 words) - 02:23, 25 June 2024
  • Thumbnail for Besins Healthcare
    conditions. In November 2022, Oregon Attorney General Ellen Rosenblum sued AbbVie, Abbott Laboratories, Unimed Pharmaceuticals. The lawsuit alleges that the...
    4 KB (331 words) - 10:48, 11 June 2024
  • October AbbVie's board recommended that shareholders vote against the deal. This news sent Shire's share price down over 27%; however, AbbVie would be...
    41 KB (3,016 words) - 20:43, 31 December 2023
  • Results - AbbVie News Center". news.abbvie.com. "Financial Release - AbbVie". investors.abbvie.com. "Financial Release - AbbVie". investors.abbvie.com. "Financial...
    61 KB (2,699 words) - 04:11, 10 June 2024
  • products. It split off its research-based pharmaceuticals business into AbbVie in 2013. Abbott's products include Pedialyte, Similac, BinaxNOW, Ensure...
    63 KB (5,761 words) - 12:41, 26 June 2024
  • Thumbnail for Ibrutinib
    Ibrutinib (category Drugs developed by AbbVie)
    and $825 million in milestones. Pharmacyclics was acquired by AbbVie in May 2015, and Abbvie projected global sales of US$1 billion in 2016 and $5 billion...
    29 KB (2,605 words) - 06:34, 1 July 2024
  • Allergan (category AbbVie)
    Pharmaceuticals for $40.5 billion. In June 2019, U.S. pharmaceutical company AbbVie announced it had reached an agreement to acquire Allergan for $63 billion...
    37 KB (2,816 words) - 15:01, 4 April 2024
  • Thumbnail for Cariprazine
    Cariprazine (category Drugs developed by AbbVie)
    depressive disorder. It is being developed jointly by AbbVie and Gedeon Richter Plc, with AbbVie responsible for commercialization in the US, Canada, Japan...
    31 KB (2,618 words) - 06:03, 18 May 2024
  • company Pfizer and private equity firm Bain Capital. In December 2023, AbbVie, an American pharmaceutical company, announced its intention to acquire...
    8 KB (557 words) - 14:16, 20 June 2024
  • Thumbnail for Venetoclax
    Venetoclax (category Drugs developed by AbbVie)
    (PDUFA) date. AbbVie Inc. manufactures Venclexta. It is marketed by both Abbvie and Genentech USA, which is a member of the Roche Group. AbbVie and Genentech...
    27 KB (2,563 words) - 21:58, 1 July 2024